首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   149258篇
  免费   31159篇
  国内免费   2393篇
耳鼻咽喉   5158篇
儿科学   5333篇
妇产科学   2428篇
基础医学   2886篇
口腔科学   1469篇
临床医学   26512篇
内科学   46871篇
皮肤病学   7415篇
神经病学   14627篇
特种医学   6343篇
外科学   40746篇
综合类   232篇
现状与发展   72篇
预防医学   6919篇
眼科学   3313篇
药学   866篇
中国医学   11篇
肿瘤学   11609篇
  2024年   684篇
  2023年   4778篇
  2022年   1170篇
  2021年   3036篇
  2020年   5998篇
  2019年   2114篇
  2018年   7342篇
  2017年   7297篇
  2016年   8373篇
  2015年   8361篇
  2014年   15422篇
  2013年   15536篇
  2012年   5339篇
  2011年   5350篇
  2010年   10273篇
  2009年   14180篇
  2008年   5663篇
  2007年   3896篇
  2006年   6371篇
  2005年   3664篇
  2004年   2936篇
  2003年   1923篇
  2002年   2015篇
  2001年   3783篇
  2000年   2999篇
  1999年   3193篇
  1998年   3633篇
  1997年   3451篇
  1996年   3351篇
  1995年   3201篇
  1994年   1937篇
  1993年   1557篇
  1992年   1367篇
  1991年   1402篇
  1990年   1051篇
  1989年   1172篇
  1988年   1009篇
  1987年   846篇
  1986年   880篇
  1985年   712篇
  1984年   544篇
  1983年   517篇
  1982年   511篇
  1981年   398篇
  1980年   358篇
  1979年   306篇
  1978年   328篇
  1977年   396篇
  1975年   277篇
  1972年   302篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
111.
112.
PURPOSE: The aim of this study is (1) to develop a new method of risk classification for clinically localized prostate cancer; (2) to examine it in terms of compatibility with existing data such as nomograms; and (3) to compare it with existing risk-grouping methods. MATERIAL AND METHODS: The new grading system introduced here consists of three factors. The first is a prostate-specific antigen (PSA) of 4.1-10.0 ng/ml (score 0), 10.1-20.0 ng/ml (score 1), and >20.0 ng/ml (score 2). The second is a Gleason score (GS) of 6 (score 0), 7 (score 1), and 8-10 (score 2). The third is T classifications (UICC 2002) of T1c-T2a (score 0), T2b-T2c (score 1), and T3a (score 2). The sum of the three scores was named Prostate Risk Index (PRIX). Then, the compatibility of PRIX with the Partin Table, Kattan Nomogram, and Roach's formula was examined. At the same time, PRIX was compared with D'Amico, the National Comprehensive Cancer Network (NCCN), and Seattle classifications. RESULTS: PRIX 0 corresponded to 1-2% of pathologic lymph node involvement (pLN+) according to the Partin Table; PRIX 1 to 3-4%; PRIX 2 to 7-10%; PRIX 3 to 14-18%; PRIX 4 to 24-29%; PRIX 5 to 32-37%; and PRIX 6 to 42%. PRIX well separated the risks with relatively narrow ranges of probability, while D'Amico, NCCN, and Seattle classifications generally gave wide ranges especially for high-risk groups, both in the Partin Table and Kattan Nomogram. Roach's formula sometimes overestimated the risk compared to the Partin Table. CONCLUSION: PRIX fully corresponded to the Partin Table in terms of pLN+, and corresponded to the other nomograms better than any existing risk-grouping method. PRIX may thus function as a prognostic factor or contribute to patient selection in clinically localized prostate cancer.  相似文献   
113.
Four Chinese patients (2 boys, 2 girls), ages 4–9 years, who had episodes of perception error of body schema and objects are reported. The metamorphopsia, which had been named Alice in Wonderland syndrome, is the major presentation. All of them were proved to have acute Epstein-Barr virus infection, as documented by positive heterophil antibody test and/or positive IgM antibody to Epstein-Barr virus capsid antigen. The duration of the perception disorder ranged from 1 week to 3 months. We believe that any young child presenting with Alice in Wonderland syndrome should undergo examination for Epstein-Barr virus infection; complete recovery from the disorder can be expected.  相似文献   
114.
115.
116.
117.
118.
The red eye     
A red eye is a cardinal sign of ocular inflammation. Most cases are benign and can be managed by the primary care provider. The key is recognizing cases requiring ophthalmological consultation by differentiating between ciliary and conjunctival injection. Ciliary injection indicates inflammation of the cornea, iris, or ciliary body, whereas conjunctival injection mainly affects the posterior conjunctival blood vessels. The author has stated that he does not have a significant financial interest or other relationship with any product manufacturer or provider of services discussed in this article. The author also does not discuss the use of off-label products, which includes unlabeled, unapproved, or investigative products or devices.  相似文献   
119.
120.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号